Insulet Corp. (PODD)
131.69
+0.90
(+0.69%)
USD |
NASDAQ |
Oct 02, 16:00
131.64
-0.05
(-0.04%)
After-Hours: 20:00
Insulet Price to Book Value : 6.422 for Oct. 2, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 02, 2026 | 6.422 |
| October 01, 2026 | 6.378 |
| September 30, 2026 | 6.362 |
| September 29, 2026 | 6.478 |
| September 28, 2026 | 6.491 |
| September 25, 2026 | 6.638 |
| September 24, 2026 | 6.621 |
| September 23, 2026 | 6.656 |
| September 22, 2026 | 6.797 |
| September 21, 2026 | 6.853 |
| September 18, 2026 | 6.856 |
| September 17, 2026 | 6.902 |
| September 16, 2026 | 6.856 |
| September 15, 2026 | 6.790 |
| September 14, 2026 | 6.720 |
| September 11, 2026 | 6.435 |
| September 10, 2026 | 6.567 |
| September 09, 2026 | 6.725 |
| September 08, 2026 | 6.938 |
| September 04, 2026 | 7.192 |
| September 03, 2026 | 7.343 |
| September 02, 2026 | 7.224 |
| September 01, 2026 | 7.236 |
| August 31, 2026 | 7.249 |
| August 28, 2026 | 7.077 |
| Date | Value |
|---|---|
| August 27, 2026 | 6.993 |
| August 26, 2026 | 6.992 |
| August 25, 2026 | 6.976 |
| August 24, 2026 | 7.091 |
| August 21, 2026 | 7.225 |
| August 20, 2026 | 7.162 |
| August 19, 2026 | 7.388 |
| August 18, 2026 | 7.218 |
| August 17, 2026 | 6.812 |
| August 14, 2026 | 6.990 |
| August 13, 2026 | 7.141 |
| August 12, 2026 | 7.074 |
| August 11, 2026 | 7.056 |
| August 10, 2026 | 6.966 |
| August 07, 2026 | 6.884 |
| August 06, 2026 | 6.793 |
| August 05, 2026 | 6.498 |
| August 04, 2026 | 8.135 |
| August 03, 2026 | 8.275 |
| July 31, 2026 | 8.063 |
| July 30, 2026 | 8.079 |
| July 29, 2026 | 8.32 |
| July 28, 2026 | 8.166 |
| July 27, 2026 | 8.046 |
| July 24, 2026 | 7.961 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| DexCom, Inc. | 12.29 |
| Abbott Laboratories | 3.301 |
| Boston Scientific Corp. | 2.472 |
| PROCEPT BioRobotics Corp. | 2.889 |
| Globus Medical, Inc. | 2.128 |
Price to Book Value Related Metrics
| PE Ratio | 26.11 |
| PS Ratio | 3.029 |
| PEG Ratio | 0.4879 |
| Price to Free Cash Flow | 34.81 |
| Price | 131.69 |
| Earnings Yield | 3.83% |
| Market Cap | 9.133B |
| PEGY Ratio | 0.4879 |
| Operating PE Ratio | 17.95 |
| Normalized PE Ratio | 26.58 |